Chemotherapy Induced Peripheral Neuropathy - Drug Pipeline Landscape, 2022

Chemotherapy-induced peripheral neuropathy (CIPN) is a side effect of cancer treatment that can cause tingling, numbness, and pain in the hands and feet. CIPN is caused by damage to the nerves that send signals from the body to the brain. Chemotherapy-induced neuropathy is caused by a substantial number of cytotoxic drugs, including taxanes, platinums, vinca alkaloids, epothilones, eribulin, and bortezomib; these drugs cause different pathologic insults to neurons.

The symptoms of CIPN can range from mild to severe, and they can last for weeks, months, or even years after treatment has ended. There is no cure for CIPN, but there are treatments that can help lessen the symptoms.

Read more about Chemotherapy Induced Peripheral Neuropathy - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/chemotherapy-induced-peripheral-neuropathy-drug-pipeline-landscape-2022/

Report Highlights
Global Insight Service's, Chemotherapy Induced Peripheral Neuropathy - Drug Pipeline Landscape, 2022 report provides an overview of the Chemotherapy Induced Peripheral Neuropathy pipeline drugs. This report covers detailed insights on Chemotherapy Induced Peripheral Neuropathy drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Chemotherapy Induced Peripheral Neuropathy pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS31053/

Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Key Players:

- Advinus Therapeutics Ltd
- Algenis SpA
- AnnJi Pharmaceutical
- Asahi Kasei Pharma Corp
- AxoProtego Therapeutics
- Beijing 3E-Regenacy Pharmaceuticals Co., Ltd.
- Bexion Pharmaceuticals, Inc

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS31053/

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.